Department of Anesthesiology and Perioperative Medicine, Mayo Clinic, Jacksonville, FL.
Clin J Pain. 2024 Jun 1;40(6):367-372. doi: 10.1097/AJP.0000000000001208.
This study aimed to determine the incidence of complications after landmark-based paravertebral blocks for breast surgery.
The medical records of patients who received a paravertebral block for breast surgery between 2019 and 2022 were reviewed. Patient age, sex, type of procedure, number of injections, volume of injected anesthetic, and possible complications were noted. A record was identified as a possible serious block-related complication if there was concern or treatment for local anesthetic systemic toxicity, pneumothorax, altered mental status, or intrathecal/epidural spread. Other complications recorded were immediate postblock hypotension and nausea/vomiting requiring treatment and unanticipated postsurgical admission. Patients receiving ultrasound-guided paravertebral blocks were excluded from this study.
Over a 3-year period, 979 patients received paravertebral blocks using the landmark technique for breast surgery, totaling 4983 injections. Overall, 6 patients required assessment for postblock issues (0.61%), including hypotension (2 patients), nausea (3 patients), and hypotension + altered mental status (1 patient). This latter patient was identified as having a serious complication related to the paravertebral block (0.1%). This patient had unintentional intrathecal spread and altered mental status that required mechanical ventilation. The incidence of block-related hypotension and nausea requiring treatment was thus 0.31% and 0.31% respectively. Four patients required unanticipated admission, but none were for block-related reasons. No patients in this study were found to have local anesthetic systemic toxicity or pneumothorax.
Our study suggests that landmark-based paravertebral blocks for breast surgery result in a very low complication rate and are a safe technique for postsurgical analgesia.
本研究旨在确定基于标志的椎旁阻滞用于乳房手术的并发症发生率。
回顾了 2019 年至 2022 年间接受椎旁阻滞用于乳房手术的患者的病历。记录了患者年龄、性别、手术类型、注射次数、注射麻醉剂的体积以及可能的并发症。如果存在局部麻醉全身毒性、气胸、意识改变或蛛网膜下腔/硬膜外扩散的担忧或治疗,则将记录视为可能的严重与阻滞相关的并发症。记录的其他并发症包括即刻阻滞后低血压和需要治疗的恶心/呕吐以及意外术后住院。本研究排除了接受超声引导椎旁阻滞的患者。
在 3 年期间,979 例患者接受了基于标志的椎旁阻滞用于乳房手术,共进行了 4983 次注射。总体而言,有 6 例患者需要评估阻滞后的问题(0.61%),包括低血压(2 例)、恶心(3 例)和低血压+意识改变(1 例)。后一例患者被认为与椎旁阻滞相关的严重并发症(0.1%)。该患者出现了意外的蛛网膜下腔扩散和意识改变,需要机械通气。因此,阻滞相关的低血压和需要治疗的恶心发生率分别为 0.31%和 0.31%。4 例患者需要意外住院,但均与阻滞无关。本研究中没有患者发现局部麻醉全身毒性或气胸。
我们的研究表明,基于标志的椎旁阻滞用于乳房手术的并发症发生率非常低,是一种安全的术后镇痛技术。